Literature DB >> 12818453

Prevalence of endometriosis in malignant epithelial ovary tumours.

Engin Oral1, Sennur Ilvan, Esra Tustas, Begum Korbeyli, Tugan Bese, Fuat Demirkiran, Macit Arvas, Derin Kosebay.   

Abstract

OBJECTIVE: To determine the prevalence of ovarian endometriosis in malignant epithelial ovarian tumours. STUDY
DESIGN: A retrospective analysis of 160 malignant and 23 borderline ovarian tumours during the period 1995-2001.
RESULTS: Fourteen (7.7%) of the tumours contained endometriosis. This affected 22% of the endometrioid and 10.8% of the mixed adenocarcinomas. The mean age of the ovarian endometriosis patients was 43+/-13 range 26-70 years. The incidence in borderline tumours 13% (3/23) was higher than that in ovarian cancer 6.9% (11/160) (P>0.05). Eight (57%) of cases were classified as atypical and six (43%) as typical endometriosis. Nine cases were FIGO (International Federation of Gynaecology and Obstetrics) stage I and 5 stage III.
CONCLUSIONS: Both malignant and borderline ovarian tumours are associated with ovarian endometriosis. In addition, atypical endometriosis was found associated with endometrioid and mixed epithelial ovarian tumours.

Entities:  

Mesh:

Year:  2003        PMID: 12818453     DOI: 10.1016/s0301-2115(03)00047-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  21 in total

Review 1.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

2.  AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma.

Authors:  Fan Yang; Xiaoqing Guo; Gong Yang; Daniel G Rosen; Jinsong Liu
Journal:  Mod Pathol       Date:  2011-03-25       Impact factor: 7.842

Review 3.  Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

Authors:  Jian-Jun Wei; Josette William; Serdar Bulun
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

4.  Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube.

Authors:  Joseph Carlson; Michael H Roh; Martin C Chang; Christopher P Crum
Journal:  Diagn Histopathol (Oxf)       Date:  2008-08

5.  Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.

Authors:  Mohamed Ali Bedaiwy; Mahmoud Rezk Abd-Elwahed Hussein; Charles Biscotti; Tommaso Falcone
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

6.  Endometriosis in a postmenopausal woman without previous hormonal therapy: a case report.

Authors:  Manuel García Manero; Pedro Royo; Begoña Olartecoechea; Juan Luis Alcázar
Journal:  J Med Case Rep       Date:  2009-11-18

7.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

8.  Endometriosis and ovarian cancer: a systematic review.

Authors:  Ahmad Sayasneh; Dimitris Tsivos; Robin Crawford
Journal:  ISRN Obstet Gynecol       Date:  2011-07-15

9.  Creation of immortalised epithelial cells from ovarian endometrioma.

Authors:  Y Bono; S Kyo; M Takakura; Y Maida; Y Mizumoto; M Nakamura; K Nomura; T Kiyono; M Inoue
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

10.  Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.

Authors:  Allan Jensen; Heidi Sharif; Kirsten Frederiksen; Susanne Krüger Kjaer
Journal:  BMJ       Date:  2009-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.